ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness

NCT07084558 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

350

Enrollment

NETWORK

Sponsor class

Conditions

Early and Locally Advanced Breast Cancer

Interventions

DIAGNOSTIC_TEST: blood sample for Signatera (TM) test
DIAGNOSTIC_TEST: biopsy for Ki-67 assessment
DIAGNOSTIC_TEST: FFPE tumor sample for Signatera (TM) test (archived)

Sponsor

Austrian Breast & Colorectal Cancer Study Group

Collaborators

[object Object]